Figure 2
From: A randomised controlled trial of bumetanide in the treatment of autism in children
All the values obtained with CARS are depicted. Note the significant differences between placebo and bumetanide treated patients and a partial return to pretreatment values after 1-month wash-out period. The number of items >3 was also significantly reduced as shown at the right side of the figure (number corresponding to D0, D90 and D120; ***p<0.005 for D90 and **p<0.05 for D120).
